Skye Bioscence’s $40 Million Private Placement Equity Financing

Paul Hastings LLP advised Piper Sandler and Co. as lead placement agent, and Oppenheimer & Co. as placement agent in the transaction.Skye Bioscience, Inc. (OTCQB: SKYE) has…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now